Syros, Incyte partner to discover targets for myeloproliferative neoplasms

Syros Pharmaceuticals Inc. (NASDAQ:SYRS) partnered with Incyte Corp. (NASDAQ:INCY) to discover therapeutic targets, with

Read the full 149 word article

User Sign In